Skip to main content

Table 1 Clinicopathological characteristics of 24 cases of PASTs

From: Clinicopathological characteristics and prognosis of primary appendiceal stromal tumors

Characteristics

N(%)

Age (year)/(Σ = 24)

 <59

11(45.8)

 ≥ 59

13(54.2)

Sex (Σ = 24)

 Male

14(58.3)

 Female

10(41.7)

Tumor size (cm)/(Σ = 24)

 ≤ 2

11(45.8)

 2.1–5.0

1(4.2)

 5.1–10

8(33.3)

 >10

4(16.7)

Gross type (Σ = 24)

 Solid

20(83.3)

 Mixed

4(16.7)

 Cystic

0(0.0)

Histologic type (Σ = 24)

 Spindle

21(87.5)

 Epithelioid

2(8.3)

 Mixed

1(4.2)

Lymph node metastasis (Σ = 24)

 Yes

1(4.2)

 No

23(95.8)

Mitotic index(%)/(Σ = 17)

 ≤ 5

14(82.4)

 >5

3(17.6)

Ki-67(%)/(Σ = 6)

 <5

4(66.7)

 ≥ 5

2(33.3)

Immunohistochemistry (Σ = 24)

 CD117 (Σ = 24)

23(95.8)

 CD34 (Σ = 20)

15(75.0)

 DOG-1 (Σ = 5)

3(60.0)

 SMA (Σ = 17)

4(23.5)

 S-100 (Σ = 24)

7(29.2)

Mutational status (Σ = 5)

 Kit

3(60.0)

 PDGFRA

0(0.0)

 Wild type

2(40.0)

 SDHB

0(0.0)

NIH risk category (Σ = 24)

 Very low risk

11(45.8)

 Low risk

2(8.3)

 Intermediate risk

4(16.7)

 High risk

7(29.2)

Rupture (Σ = 24)

 Yes

2(8.3)

 No

22(91.7)

Ulceration (Σ = 24)

 Yes

1(4.2)

 No

23(95.8)

Symptoms (Σ = 24)

 Appendicitis

14(58.3)

 Abdominal distension or pain or mass

17(70.8)

 Hematochezia or anemia

3(12.5)

 Nausea or emesis

3(12.5)

 Others

6(25.0)

  1. PASTs primary appendiceal stromal tumors, NIH National Institute of Health